Yuhan Outlines Clinical Progress for Oral Targeted Anticancer Candidate YH42946 at WCLC 2026
Yuhan Corporation has detailed the status and trial design of the ongoing Phase 1/2 clinical study for YH42946, an oral targeted anticancer candidate...
Search results for "research and development"
Cell and Gene Therapy Advances Take Center Stage at Samsung Joint International Symposium
Leading researchers developing stem cell and extracellular vesicle therapies for sepsis, personalized mRNA vaccines for pediatric brain tumors, and...
GC Pharma’s Homegrown mRNA Vaccine Advances to Phase 2 Trials
GC Pharma announced on the 11th that South Korea’s Ministry of Food and Drug Safety has approved its Phase 2 clinical...
Robots Respond to ‘Scalpel, Please’: Samsung Medical Center Unveils World-First Dual-Humanoid Surgical Team
Humanoid robots capable of responding to voice commands and handing surgical instruments directly to doctors are...
‘Singapore Is the Bridge, Not the Destination’: Novo Holdings Connects Asian Biotech to Global Capital
Global life sciences investment firm Novo Holdings is bringing its proven European biotech company-building playbook to...
“I Dream of an Ordinary Life”: Expanded Insurance Coverage Brings New Hope to Dravet Syndrome Families
“Until just before my daughter turned 2, she frequently suffered not only febrile seizures but also afebrile seizures.
Customizable Artificial Ear Bone Allows Fine-Tuning During Surgery to Restore Hearing
Patients suffering from conductive hearing loss caused by damaged middle ear bones may soon benefit from a new surgical...
Turning Off Cancer Signals: New Precision Drug Stops Tumors Without Harming Healthy Cells
South Korean researchers have developed a novel anticancer approach capable of selectively turning off specific...
Celltrion to Select Japanese Biotech Startups for Joint R&D and Pipeline Expansion
Celltrion is stepping up efforts to identify and foster promising biotech startups in Japan.
Kyungdong Pharmaceutical and AUL Bio Seek Phase 1 Approval for Once-Monthly Obesity Drug AUL009
Kyungdong Pharmaceutical announced Sept. 2 that it has submitted an investigational new drug application to the...